Scarica l'app Stockscreener
287.21
0.02%
0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
10 Undervalued Stocks That Crushed Q2 Earnings - Morningstar
What’s next for Bio Rad Laboratories Inc. stockMarket Volume Report & Weekly High Potential Alerts - sundaytimes.kr
Can Bio Rad Laboratories Inc. sustain earnings growthEarnings Growth Report & Stepwise Entry and Exit Trade Signals - thegnnews.com
Protein Chip Market Future Business Opportunities 2025-2032 | - openPR.com
Bio-Rad Laboratories: Is The Growth in Digital PCR Business Here To Stay? - Smartkarma
Cell Separation Technology Market Set to Witness Significant - openPR.com
Mexico Microcarrier Market Trends and Company Analysis - GlobeNewswire
Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge - Yahoo Finance
STD Diagnostic Market Forecast and Company Analysis Report - GlobeNewswire
STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories - Yahoo Finance
Is Bio Rad Laboratories Inc. stock overvalued or fairly pricedHigh Return Stock Ideas - mustnews.co.kr
Bio-Rad Laboratories shares rise 8.44% intraday after market report predicts 10.2% CAGR in molecular quality control market. - AInvest
Global Gene Amplification Technologies Market Is Booming So - openPR.com
How the Molecular Quality Controls Market Will Evolve by 2032 - openPR.com
Unexpected Trends Reshaping the Neuroscience Antibodies - openPR.com
Monoclonal Antibody Diagnostic Reagents Market Set to Witness - openPR.com
Bio Rad Laboratories Inc. Moves Into Bullish Territory Based on MACDBuy Alerts With Low Risk Confirmation Noted - beatles.ru
Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause - Seeking Alpha
Enzyme Linked Immunosorbent Assay Market: Analysis of Size, - openPR.com
Hemoglobin A1c Testing Devices Market to Grow at 8.8% CAGR by 2030 - openPR.com
Porphyria Treatment Market Growth in Future Scope 2025-2032 - openPR.com
Protein Expression Market Forecast 2024-2031 | Growth & - openPR.com
Lateral Flow Assay Market Boosted by Point-of-Care Testing - openPR.com
Digital Pcr And Real Time Pcr Market Set to Witness Significant - openPR.com
Bio-Rad Laboratories B (BIO.B) Surges 11.58% Intraday: What's Fueling This Sharp Uptick? - AInvest
Cardiac Marker Testing Devices Market Is Booming So Rapidly - openPR.com
Bio-Rad Laboratories (NYSE:BIO) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Bio Rad Laboratories Inc. Sees Spike in Bullish Option FlowDaily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
How does Bio Rad Laboratories Inc. compare to its industry peersIdentify undervalued stocks ready to soar - Jammu Links News
What drives Bio Rad Laboratories Inc. stock priceConsistently high returns - Jammu Links News
What are the latest earnings results for Bio Rad Laboratories Inc.Accelerated investment success - Jammu Links News
What institutional investors are buying Bio Rad Laboratories Inc. stockAchieve rapid financial growth with expert help - Jammu Links News
What are analysts’ price targets for Bio Rad Laboratories Inc. in the next 12 monthsStrong return on investment - Jammu Links News
Bio-Rad raises 2025 life science guidance to flat to 1% growth and expands ddPCR portfolio following Stilla acquisition - MSN
Bio-Rad Laboratories, Inc.'s (NYSE:BIO) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - 富途牛牛
Bio-Rad Laboratories’ Stock Jumps on Positive Q2 Performance - timothysykes.com
Analysts Are Updating Their Bio-Rad Laboratories, Inc. (NYSE:BIO) Estimates After Its Second-Quarter Results - simplywall.st
Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its Second-Quarter Results - Yahoo Finance
Is Bio Rad Laboratories Inc. a good long term investmentBreakout stock performance - Jammu Links News
Why is Bio Rad Laboratories Inc. stock attracting strong analyst attentionUnstoppable investment returns - Jammu Links News
Does Bio Rad Laboratories Inc. stock perform well during market downturnsBuild your wealth with consistent stock growth - Jammu Links News
When is Bio Rad Laboratories Inc. stock expected to show significant growthIdentify safe investments with exceptional yields - Jammu Links News
How volatile is Bio Rad Laboratories Inc. stock compared to the marketIdentify winners with top-tier analysis - Jammu Links News
Is Bio Rad Laboratories Inc. a growth stock or a value stockDiscover top stock picks for aggressive growth - Jammu Links News
How does Bio Rad Laboratories Inc. generate profit in a changing economyPhenomenal investment performance - Jammu Links News
Bio-Rad Laboratories: A Case for Long-Term Growth in the Life Sciences Sector - AInvest
Bio-Rad Laboratories Surges as Analysts Boost Price Targets - StocksToTrade
Bio-Rad Laboratories, Inc. (NYSE:BIO) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Yahoo Finance
Bio-Rad Laboratories Second Quarter 2025 Earnings: EPS: US$11.67 (vs US$76.26 loss in 2Q 2024) - Yahoo Finance
Bio-Rad (BIO) Beats Q2 Earnings Estimates, Boosts Outlook With Strong Revenue Growth - Insider Monkey
Bio-Rad Q2 2025 net sales up 2.1% to USD 651.6M - Medical Buyer
Bio-Rad Reports Q2 2025 Financial Results - The Globe and Mail
Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings - 富途牛牛
Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025 - BioSpace
Bio-Rad Laboratories (BIO) Soars 18% on Regulatory Shifts and Sector Momentum – What’s Fueling the Surge? - AInvest
RBC Capital Raises Price Target for Bio-Rad Laboratories (BIO) t - GuruFocus
2.30%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):